Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Linyi Liu
Institution:
University of South China
Observed institutions:
ShanghaiTech University,
University of South China
ORCID:
0000-0002-7646-8537
Observed ORCID:
0000-0002-7646-8537
OpenAlex ID:
A5061074146
Design, synthesis and biological evaluation of 3-arylisoquinoline derivatives as topoisomerase I and II dual inhibitors for the therapy of liver cancer
2022
·
Xuemei Deng
, Tian Luo
, et al.
·
European Journal of Medicinal Chemistry
·
17
Identification of a novel 10-hydroxyevodiamine prodrug as a potent topoisomerase inhibitor with improved aqueous solubility for treatment of hepatocellular carcinoma
2024
·
Xiuzhen Wei
, Xi Zhang
, et al.
·
European Journal of Medicinal Chemistry
·
12
Design, synthesis and biological evaluation of novel quinazolinone derivatives as CRBN E3 ligase modulators
2022
·
Linyi Liu
, Renhong Sun
, et al.
·
European Journal of Medicinal Chemistry
·
6
Novel N-phenyl-2-(aniline) benzamide hydrochloride salt development for colon cancer therapy
2024
·
Yan Peng
, Ying Peng
, et al.
·
Frontiers in Pharmacology
·
1
PDF
Show more works
View as search
Works count:
4
Citation count:
36
H-index:
3
I10-index:
2
Year
Topic
Type